Back
Sangamo Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
SGMO
Sangamo Therapeutics
Last Price:
1.95
Seasonality Move:
29.11%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Sangamo Therapeutics Price Quote
$1.95
Sangamo Therapeutics Key Stats
Sell
48
Sangamo Therapeutics (SGMO)
is a Sell
Day range:
$1.89 - $2.11
52-week range:
$0.30 - $3.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.05
P/B ratio:
10.13%
Volume:
6.6M
Avg. volume:
11.8M
1-year change:
369.88%
Market cap:
$396.4M
Revenue:
$176.2M
EPS:
$-0.75
How Much Does Sangamo Therapeutics Make?
-
How Much Are Sangamo Therapeutics's Sales Annually?
SGMO Revenues are $176.2M -
How Much Profit Does Sangamo Therapeutics's Make A Year?
SGMO net income is -$257.8M
Is Sangamo Therapeutics Growing As A Company?
-
What Is Sangamo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 4.26% -
What Is Sangamo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sangamo Therapeutics Stock Price Performance
-
Did Sangamo Therapeutics Stock Go Up Last Month?
Sangamo Therapeutics share price went up by 111.8% last month -
Did SGMO's Share Price Rise Over The Last Year?
SGMO share price rose by 369.88% over the past 1 year
What Is Sangamo Therapeutics 52-Week High & Low?
-
What Is Sangamo Therapeutics’s 52-Week High Share Price?
Sangamo Therapeutics has traded as high as $3.18 over the past 52 weeks -
What Is Sangamo Therapeutics’s 52-Week Low Share Price?
Sangamo Therapeutics has traded as low as $0.30 over the past 52 weeks
Sangamo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sangamo Therapeutics?
-
How Much Debt Does Sangamo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sangamo Therapeutics Have?
Cash and short term investments quarterly total is $39.2M -
What Is Sangamo Therapeutics’s Book Value Per Share?
Book value per share is 0.19
Is Sangamo Therapeutics Cash Flow Positive?
-
What Is SGMO Cash Flow From Operations?
Cash flow from operations (TTM) is -$114.3M -
What Is Sangamo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $21.6M -
What Is Sangamo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $73.9M
Sangamo Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SGMO return on invested capital is -199.86% -
What Is Sangamo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -93.87% -
What Is SGMO Return On Equity?
ROE is a measure of profitability and is -199.86%
Sangamo Therapeutics Earnings Date & Stock Price
-
What Is Sangamo Therapeutics's Stock Price Today?
A single share of SGMO can be purchased today for 1.95 -
What Is Sangamo Therapeutics’s Stock Symbol?
Sangamo Therapeutics trades on the nasdaq under the ticker symbol: SGMO -
When Is Sangamo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sangamo Therapeutics is scheduled on March 13, 2025 -
When Is SGMO's next ex-dividend date?
Sangamo Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy Sangamo Therapeutics Stock?
You can buy Sangamo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sangamo Therapeutics Competitors
-
Who Are Sangamo Therapeutics's Competitors?
Below is a list of companies who compete with Sangamo Therapeutics or are related in some way:
Sangamo Therapeutics Dividend Yield
-
What Is SGMO Dividend Yield?
Sangamo Therapeutics’s dividend yield currently is 0% -
What Is Sangamo Therapeutics’s Payout Ratio?
Sangamo Therapeutics’s payout ratio is 0% -
When Did Sangamo Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Sangamo Therapeutics’s Dividend Per Share?
Sangamo Therapeutics pays a dividend of $0.00 per share
Sangamo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 425.77% | 97.09% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 6.20 |
| Upside from Last Price: | 217.95% |